A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A
Public ClinicalTrials.gov record NCT03316300. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Multicenter Randomized, Sham Controlled, Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2
Study identification
- NCT ID
- NCT03316300
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Neurotech Pharmaceuticals
- Industry
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Interventions
- NT-501 Combination Product
- Sham Procedure Procedure
Combination Product · Procedure
Eligibility (public fields only)
- Age range
- 21 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 23, 2017
- Primary completion
- Aug 30, 2022
- Completion
- Sep 22, 2022
- Last update posted
- Sep 23, 2024
2017 – 2022
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Scripps Clinic Medical Group | La Jolla | California | 92037 | — |
| Jules Stein Eye Institute / David Geffen School of Medicine | Los Angeles | California | 90095 | — |
| Byers Eye Institute at Stanford University | Palo Alto | California | 94303 | — |
| Bay Area Retina Associates | Walnut Creek | California | 94598 | — |
| Retina Consultants of Southern Colorado, P.C. | Colorado Springs | Colorado | 80909 | — |
| Retina Associates of New Orleans | Metairie | Louisiana | 70006 | — |
| National Institute of Health, NIH | Bethesda | Maryland | 20892 | — |
| Cumberland Valley Retina Consultants | Hagerstown | Maryland | 21740 | — |
| Associated Retinal Consultants, P.C. | Royal Oak | Michigan | 48073 | — |
| Sierra Eye Associates | Reno | Nevada | 89502 | — |
| Retina Associates of Cleveland, Inc. | Cleveland | Ohio | 44122 | — |
| Tulsa Retina Consultants | Tulsa | Oklahoma | 74114 | — |
| Retina Northwest, PC | Portland | Oregon | 97221 | — |
| Southeastern Retina Associates, PC | Knoxville | Tennessee | 37922 | — |
| Texas Retina Associates | Dallas | Texas | 75231 | — |
| University of Utah John A. Moran Eye Center | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03316300, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 23, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03316300 live on ClinicalTrials.gov.